Julia C. Prentice, PhD

Associate Professor, Psychiatry

Julia Prentice
1400 VFW Parkway

Biography

Dr. Prentice is Director of the Health Care Financing and Economics (HCFE) group at the VA Boston Healthcare System and holds faculty appointments in the Boston University School of Medicine and Public Health. Her current research focuses on the comparative effectiveness of medications and the validation of access metrics using patient-level outcomes. This work utilizes econometric methods to supplement randomized trial evidence with data analyses based on quasi-experimental designs. These results have allowed her to identify health risks of medication regimes not identified by other approaches. Her research on access to care in veteran populations has helped to shape national Department of Veterans Affairs policies for collecting and evaluating appointment wait times in responses to recent VA access crises. She is co-principal investigator of the Partnered Evidence Based Resource Center (PEPReC) that provides timely, rigorous data analysis to support the development of high-priority policy, planning, and management initiatives and randomized program evaluations within VA healthcare.

Other Positions

  • VA Boston Healthcare System

Education

  • University of California, Los Angeles, PhD
  • University of California, Los Angeles, MSPH
  • Grinnell College, AB

Publications

  • Published on 6/3/2018

    Frakt AB, Prentice JC, Pizer SD, Elwy AR, Garrido MM, Kilbourne AM, Atkins D. Overcoming Challenges to Evidence-Based Policy Development in a Large, Integrated Delivery System. Health Serv Res. 2018 Jun 03. PMID: 29862494.

    Read at: PubMed
  • Published on 3/21/2017

    Edwards ST, Saha S, Prentice JC, Pizer SD. Preventing Hospitalization with Veterans Affairs Home-Based Primary Care: Which Individuals Benefit Most? J Am Geriatr Soc. 2017 Aug; 65(8):1676-1683. PMID: 28323324.

    Read at: PubMed
  • Published on 7/17/2016

    Prentice JC, Pizer SD, Conlin PR. Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes. Diabet Med. 2016 Dec; 33(12):1640-1648. PMID: 27279250.

    Read at: PubMed
  • Published on 4/1/2016

    Prentice JC, Frakt AB, Pizer SD. Metrics That Matter. J Gen Intern Med. 2016 Apr; 31 Suppl 1:70-3. PMID: 26951272.

    Read at: PubMed
  • Published on 3/1/2015

    Prentice JC, Conlin PR, Gellad WF, Edelman D, Lee TA, Pizer SD. Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus. Am J Manag Care. 2015 Mar 01; 21(3):e235-43. PMID: 26014311.

    Read at: PubMed
  • Published on 11/6/2014

    Prentice JC, Conlin PR, Gellad WF, Edelman D, Lee TA, Pizer SD. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes. Value Health. 2014 Dec; 17(8):854-62. PMID: 25498781.

    Read at: PubMed
  • Published on 11/1/2014

    Edwards ST, Prentice JC, Simon SR, Pizer SD. Home-based primary care and the risk of ambulatory care-sensitive condition hospitalization among older veterans with diabetes mellitus. JAMA Intern Med. 2014 Nov; 174(11):1796-803. PMID: 25221986.

    Read at: PubMed
  • Published on 11/1/2013

    Prentice JC, Dy S, Davies ML, Pizer SD. Using health outcomes to validate access quality measures. Am J Manag Care. 2013 Nov; 19(11):e367-77. PMID: 24511995.

    Read at: PubMed
  • Published on 8/12/2013

    Prentice JC, Davies ML, Pizer SD. Which outpatient wait-time measures are related to patient satisfaction? Am J Med Qual. 2014 May-Jun; 29(3):227-35. PMID: 23939488.

    Read at: PubMed
  • Published on 11/1/2011

    Pizer SD, Prentice JC. What are the consequences of waiting for health care in the veteran population? J Gen Intern Med. 2011 Nov; 26 Suppl 2:676-82. PMID: 21989621.

    Read at: PubMed

View 12 more publications: View full profile at BUMC

View all profiles